Borensztajn Keren, Sobrier Marie-Laure, Fischer Anne-Marie, Chafa Ouerdia, Amselem Serge, Tapon-Bretaudiere Jacqueline
INSERM U428, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V, France.
Blood. 2003 Jul 15;102(2):561-3. doi: 10.1182/blood-2002-09-2951. Epub 2003 Apr 3.
In a patient with lethal factor VII (FVII) deficiency, 2 homozygous nucleotide substitutions were identified in the F7 gene: a IVS7+2T>G transversion involving the IVS7 donor splice site, followed by a mutation at nucleotide 10588 that would result in a missense variation (Arg224Gln). The mutated splice site, located within the first repeat of a minisatellite, is followed by a variable number of pseudo-sites, normally silent. To investigate the consequences of this mutation on F7 splicing, we designed normal and mutant minigenes, spanning exons 5 to 8. In cells transfected with the mutant construct, no normal splicing occurred. Only spliced transcripts including the first minisatellite repeat were observed, resulting from the activation of the most proximal wild-type pseudo-site, which would generate a truncated protein (stop codon upstream of nucleotide 10588). These findings, which suggest the existence of a mechanism selecting one single splice site among multiple cryptic sites, explain the patient's phenotype.